The role of vitamin E and C therapy in NASH.
Stephen A
SA
Harrison
John A
JA
Ward
Steven
S
Schenker
D000704:Analysis of Variance; D000975:Antioxidants / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001707:Biopsy, Needle; D019587:Dietary Supplements; D005234:Fatty Liver / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011336:Probability; D016032:Randomized Controlled Trials as Topic; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014810:Vitamin E / Q000627:therapeutic use*
D000975:Antioxidants; D014810:Vitamin E; D001205:Ascorbic Acid